Sell-side bullish on Karyopharm

Karyopharm Therapeutics (KPTI +1.9%) rallies after receiving a bevy of upbeat coverage initiations.

Starting coverage with bullish ratings are Leerink (PT $23), JMP (PT $25), Oppenheimer (PT $23), and BofA (PT $24).

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs